Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Brugada syndrome trafficking–defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels
Marta Pérez-Hernández, Marcos Matamoros, Silvia Alfayate, Paloma Nieto-Marín, Raquel G. Utrilla, David Tinaquero, Raquel de Andrés, Teresa Crespo, Daniela Ponce-Balbuena, B. Cicero Willis, Eric N. Jiménez-Vazquez, Guadalupe Guerrero-Serna, Andre M. da Rocha, Katherine Campbell, Todd J. Herron, F. Javier Díez-Guerra, Juan Tamargo, José Jalife, Ricardo Caballero, Eva Delpón
Marta Pérez-Hernández, Marcos Matamoros, Silvia Alfayate, Paloma Nieto-Marín, Raquel G. Utrilla, David Tinaquero, Raquel de Andrés, Teresa Crespo, Daniela Ponce-Balbuena, B. Cicero Willis, Eric N. Jiménez-Vazquez, Guadalupe Guerrero-Serna, Andre M. da Rocha, Katherine Campbell, Todd J. Herron, F. Javier Díez-Guerra, Juan Tamargo, José Jalife, Ricardo Caballero, Eva Delpón
View: Text | PDF
Research Article Cardiology Cell biology

Brugada syndrome trafficking–defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels

  • Text
  • PDF
Abstract

Cardiac Nav1.5 and Kir2.1–2.3 channels generate Na (INa) and inward rectifier K (IK1) currents, respectively. The functional INa and IK1 interplay is reinforced by the positive and reciprocal modulation between Nav15 and Kir2.1/2.2 channels to strengthen the control of ventricular excitability. Loss-of-function mutations in the SCN5A gene, which encodes Nav1.5 channels, underlie several inherited arrhythmogenic syndromes, including Brugada syndrome (BrS). We investigated whether the presence of BrS-associated mutations alters IK1 density concomitantly with INa density. Results obtained using mouse models of SCN5A haploinsufficiency, and the overexpression of native and mutated Nav1.5 channels in expression systems — rat ventricular cardiomyocytes and human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) — demonstrated that endoplasmic reticulum (ER) trafficking–defective Nav1.5 channels significantly decreased IK1, since they did not positively modulate Kir2.1/2.2 channels. Moreover, Golgi trafficking–defective Nav1.5 mutants produced a dominant negative effect on Kir2.1/2.2 and thus an additional IK1 reduction. Moreover, ER trafficking–defective Nav1.5 channels can be partially rescued by Kir2.1/2.2 channels through an unconventional secretory route that involves Golgi reassembly stacking proteins (GRASPs). Therefore, cardiac excitability would be greatly affected in subjects harboring Nav1.5 mutations with Golgi trafficking defects, since these mutants can concomitantly trap Kir2.1/2.2 channels, thus unexpectedly decreasing IK1 in addition to INa.

Authors

Marta Pérez-Hernández, Marcos Matamoros, Silvia Alfayate, Paloma Nieto-Marín, Raquel G. Utrilla, David Tinaquero, Raquel de Andrés, Teresa Crespo, Daniela Ponce-Balbuena, B. Cicero Willis, Eric N. Jiménez-Vazquez, Guadalupe Guerrero-Serna, Andre M. da Rocha, Katherine Campbell, Todd J. Herron, F. Javier Díez-Guerra, Juan Tamargo, José Jalife, Ricardo Caballero, Eva Delpón

×

Figure 5

Effects of trafficking-defective Nav1.5 mutants on sodium current and inward rectifier current generated in human induced pluripotent stem cell–derived cardiomyocytes.

Options: View larger image (or click on image) Download as PowerPoint
Effects of trafficking-defective Nav1.5 mutants on sodium current and in...
(A and B) Sodium current (INa) traces recorded in DF19-9-11T (A) or in iCell2 (B) human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) expressing or not Ad-Nav1.5 WT or Nav1.5 mutants by applying 100-ms pulses from –160 mV to potentials ranging between –80 and +45 mV in 5-mV steps (A) or 50-ms pulses from –120 mV to potentials ranging between –90 and +40 mV in 5-mV steps (B). (C and D) Mean peak current density-voltage curves for INa recorded in DF19-9-11T (C) or in iCell2 (D) hiPSC-CMs expressing or not (black circles) Ad-Nav1.5 WT (white circles) or p.G1748D (white triangles), p.D1690N (white diamonds), and p.R878C (white squares). (E and F) Inward rectifier current traces recorded in DF19-9-11T (E) or in iCell2 (F) hiPSC-CMs expressing or not Ad-Nav1.5 WT or Nav1.5 mutants by applying 400-ms (E) or 250-ms (F) pulses from –40 mV to potentials ranging between –120 and –40 mV in 10-mV steps. (G and H) Mean current density-voltage curves for the inward rectifier current recorded in DF19-9-11T (G) or iCell2 (H) hiPSC-CMs expressing or not Ad-Nav1.5 WT or the indicated Nav1.5 mutants. In A, B, E, and F, dashed lines represent the zero current level. In C, D, G, and H, each point represents mean ± SEM of n experiments from at least 5 different dishes. One-way ANOVA followed by Newman-Keuls and multilevel mixed-effects model were used for comparisons.*P < 0.05 vs. noninfected; #P < 0.05 vs. Ad-Nav1.5.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts